Skip to main content
Log in

Substituting Prednisolone for Methylprednisolone Improved ESR and Eosinophilia in a Patient with Systemic Lupus Erythematosus

  • Case Report
  • Published:
BioDrugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Athens JW. Variations of leukocytes in disease. In: Lee GR, Bithell TC, Foerster J, et al., editors. Wintrobes’s clinical hematology. 9th ed. Philadelphia (PA): Lea & Febiger, 1993; 1573–6

    Google Scholar 

  2. Goldfien A. Adrenocorticosteroids and adrenocortical antagonists. In: Katzung BG, editor. Basic & clinical pharmacology. 5th ed. Connecticut: LANGE Medical Books USA. Prentice-Hall International Inc., 1992: 543–58

    Google Scholar 

  3. Matsukawa Y, Tokumaru H, Iwasaki Y, et al. D-penicillamine-induced jaundice in a patient with rheumatoid arthritis: some suggestion of type IV hypersensitivity. Jpn J Rheumatol 1994; 5: 145–50

    Google Scholar 

  4. Matsukawa Y, Saito N, Nishinarita S, et al. Therapeutic effect of tiopronin following D-penicillamine toxicity in a patient with rheumatoid arthritis. Clin Rheumatol 1998; 17: 73–4

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsukawa, Y., Kujime, K., Mitamura, K. et al. Substituting Prednisolone for Methylprednisolone Improved ESR and Eosinophilia in a Patient with Systemic Lupus Erythematosus. BioDrugs 12, 359–361 (1999). https://doi.org/10.2165/00063030-199912050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00063030-199912050-00004

Keywords

Navigation